MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF
Anjan K Pradhan1, Praveen Bhoopathi1, Sarmistha Talukdar1
1Department of Human and Molecular Genetics, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298.
Abstract:
Melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24) is a multifunctional cytokine displaying broad-spectrum anticancer activity in vitro or in vivo in preclinical animal cancer models and in a phase 1/2 clinical trial in patients with advanced cancers. mda-7/IL-24 targets specific miRNAs, including miR-221 and miR-320, for down-regulation in a cancer-selective manner. We demonstrate that mda-7/IL-24, administered through a replication incompetent type 5 adenovirus (Ad.mda-7) or with His-MDA-7/IL-24 protein, down-regulates DICER, a critical regulator in miRNA processing. This effect is specific for mature miR-221, as it does not affect Pri-miR-221 expression, and the DICER protein, as no changes occur in other miRNA processing cofactors, including DROSHA, PASHA, or Argonaute. DICER is unchanged by Ad.mda-7/IL-24 in normal immortal prostate cells, whereas Ad.mda-7 down-regulates DICER in multiple cancer cells including glioblastoma multiforme and prostate, breast, lung, and liver carcinoma cells. MDA-7/IL-24 protein down-regulates DICER expression through canonical IL-20/IL-22 receptors. Gain- and loss-of-function studies confirm that overexpression of DICER rescues deregulation of miRNAs by mda-7/IL-24, partially rescuing cancer cells from mda-7/IL-24-mediated cell death. Stable overexpression of DICER in cancer cells impedes Ad.mda-7 or His-MDA-7/IL-24 inhibition of cell growth, colony formation, PARP cleavage, and apoptosis. In addition, stable overexpression of DICER renders cancer cells more resistant to Ad.mda-7 inhibition of primary and secondary tumor growth. MDA-7/IL-24-mediated regulation of DICER is reactive oxygen species-dependent and mediated by melanogenesis-associated transcription factor. Our research uncovers a distinct role of mda-7/IL-24 in the regulation of miRNA biogenesis through alteration of the MITF-DICER pathway.
Insights
Melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24) targets DICER, a key miRNA processing enzyme, in cancer cells. This regulation, dependent on reactive oxygen species and MITF, impacts cancer cell death and tumor growth.
Area of Science:
- Molecular Biology
- Cancer Biology
- Gene Therapy
Background:
- Melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24) exhibits broad-spectrum anticancer activity.
- mda-7/IL-24 selectively targets specific microRNAs (miRNAs) for downregulation in cancer cells.
- The precise mechanisms underlying mda-7/IL-24's anticancer effects, particularly its impact on miRNA biogenesis, require further elucidation.
Purpose of the Study:
- To investigate the role of mda-7/IL-24 in regulating miRNA processing, focusing on DICER.
- To determine the cancer-selective nature of mda-7/IL-24-mediated DICER downregulation.
- To explore the downstream consequences of DICER modulation by mda-7/IL-24 on cancer cell behavior and tumor growth.
Main Methods:
- Administration of mda-7/IL-24 via adenovirus (Ad.mda-7) or protein to cancer and normal cells.
- Analysis of DICER, DROSHA, PASHA, and Argonaute expression levels.
- Gain- and loss-of-function studies involving DICER overexpression.
- Assessment of cell viability, apoptosis, colony formation, and tumor growth inhibition.
- Investigation of reactive oxygen species (ROS) dependence and the role of melanogenesis-associated transcription factor (MITF).
Main Results:
- mda-7/IL-24, delivered by Ad.mda-7 or protein, specifically downregulates DICER in various cancer cells but not normal prostate cells.
- This downregulation affects mature miR-221 but not Pri-miR-221, and is mediated through IL-20/IL-22 receptors.
- Overexpression of DICER rescues miRNA deregulation, partially protects cancer cells from mda-7/IL-24-induced cell death, and confers resistance to growth inhibition and tumor growth suppression.
- mda-7/IL-24's regulation of DICER is ROS-dependent and involves the MITF pathway.
Conclusions:
- mda-7/IL-24 regulates miRNA biogenesis by downregulating DICER in a cancer-selective manner.
- The MITF-DICER pathway is a novel target for mda-7/IL-24's anticancer activity.
- Modulating DICER levels influences cancer cell sensitivity to mda-7/IL-24 therapy, suggesting potential therapeutic strategies.
Related Concept Videos
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
GTPases and their Regulation
Large G-proteins,...
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme Kinetics
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
piRNA - Piwi-interacting RNAs


